Final Programme - iuphar

FC08 Development in the treatment of sexual dysfunction
and diseases of the lower urinary tract
Leaders: Karl-Erik Andersson, (USA) & Francois Giuliano, (France)
FC08.2 Pharmacological treatment of lower urinary tract syndrome/benign
prostatic hyperplasia
Chairs: Karl-Erik Andersson, (USA) & Francois Giuliano, (France)
09:30 - 09:55 FC08.2.1 Central pharmacological targets for the treatment of ejaculatory disorders
Francois Giuliano, (France)
09:55 - 10:20 FC08.2.2 Sensory functions as a basis for symptoms and therapy in the overactive bladder
Karl-Erik Andersson, (USA)
10:20 - 10:45 FC08.2.3 GnRH antagonists – from basic science to the clinic in BPH and lower urinary tract
symptoms (LUTS)
Enrico Colli, (Denmark)
10:45 - 11:15 COFFEE BREAK
11:15 - 11:40 FC08.2.4 BPH – beyond alpha-adrenoceptors and 5a-reductase
Christian Gratzke, (Germany)
11:40 - 11:55 FC08.2.5 Free Communication Presentation:
Hypoxic vasodilatation of penile arteries: involvement of nitric oxide (NO) and modulation
by reactive oxygen species (ROS)
Dolores Prieto, (Spain), P Kaminski, M Ahmad, MS Wolin
11:55 - 12:10 FC08.2.6 Free Communication Presentation:
Loss of balance between excitatory P2X3 and inhibitory A1 receptors contribute to
cholinergic hyperactivity in the obstructed human bladder
Miguel Silva-Ramos, (Portugal), I Silva, M Duarte-Araújo, T Magalhães-Cardoso,
J Lafuente-de-carvalho, P Correia-de-Sá
Tuesday 20 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3 69